A new IRDiRC feature article published in Drug Discovery Today provides a comprehensive assessment of non-oncology orphan drug development, focusing on productivity and the probability of success for therapies targeting rare diseases outside of cancer. The article, titled “Non-oncology orphan drug development: Productivity and probability of success, highlights several important trends: While rare diseases collectively affect hundreds of millions of […]
Read More
